Lineage Cell Therapeutics (LCTX) Other Non-Current Assets (2010 - 2023)
Lineage Cell Therapeutics (LCTX) posted Other Non-Current Assets of $552,000 for Q3 2023, down 6.6% from $591,000 a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Other Non-Current Assets (2010 - 2023) Analysis & Trends
At the end of FY2022, Lineage Cell Therapeutics' Other Non-Current Assets came in at $627,000, down 0.5% from FY2021.
- Annual Other Non-Current Assets shows a five-year compound annual growth rate of -9.2% (FY2017 to FY2022).
- In prior years, Lineage Cell Therapeutics' Other Non-Current Assets was $630,000 in FY2021 (+2.3%), $616,000 in FY2020 (+2.8%), $599,000 in FY2019 (+18.6%) and $505,000 in FY2018 (-50.4%).
- The Q3 2023 figure stands as the lowest quarterly Other Non-Current Assets since Q4 2018.
- On a year-over-year basis, Other Non-Current Assets has declined in each of the last six quarters, with an average decline of 0.8% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2019, with growth of 277.1%; the weakest was Q4 2018, with a decline of 50.4%.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $588,000 (Q2 2023), $635,000 (Q1 2023) and $627,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 588,000.00 |
| Mar 31, 2023 | 635,000.00 |
| Dec 31, 2022 | 627,000.00 |
| Sep 30, 2022 | 591,000.00 |
| Jun 30, 2022 | 598,000.00 |
| Mar 31, 2022 | 639,000.00 |
| Dec 31, 2021 | 630,000.00 |
| Sep 30, 2021 | 614,000.00 |
| Jun 30, 2021 | 610,000.00 |
| Mar 31, 2021 | 601,000.00 |
| Dec 31, 2020 | 616,000.00 |
| Sep 30, 2020 | 666,000.00 |
| Jun 30, 2020 | 649,000.00 |
| Mar 31, 2020 | 557,000.00 |
| Dec 31, 2019 | 599,000.00 |
| Sep 30, 2019 | 826,000.00 |
| Jun 30, 2019 | 815,000.00 |
| Mar 31, 2019 | 890,000.00 |
| Dec 31, 2018 | 505,000.00 |
API Access
Lineage Cell Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();